These Houston-area entrepreneurs have something to celebrate this week. Photos courtesy of EY

Four entrepreneurs whose companies are in or near the Houston metro area have been named winners in Ernst & Young’s Entrepreneur Of The Year regional competition and now will head to the national competition.

Local winners of the Entrepreneur Of The Year 2022 Central South Award are:

  • Elliott Bouillion, founder and executive chairman of Bellaire-based Resource Environmental Solutions. The company helps clients with environmental mitigation, stormwater management and water quality, and climate adaptation and flood resilience.
  • Blake Brannon, founder and president of Brenham-based Brannon Industrial Group. The company buys and recycles scrap metal, provides waste and recycling services, rents out portable toilets, and offers sustainable printing services.
  • Dr. Juliet Breeze, founder and CEO of Houston-based Next Level Medical, which operates membership-model urgent care clinics.
  • Jamie Welch, president, CEO, and chief financial officer of Houston-based Kinetic Holdings, a midstream oil and natural gas operator in the Delaware Basin of West Texas and northern New Mexico.

Among the criteria used to select the regional winners were purpose, growth, impact, and entrepreneurial spirit.

“Each of these entrepreneurs has exhibited curiosity, ingenuity, and courage, and we are proud to celebrate this outstanding group of leaders and welcome them as valuable members of our Entrepreneur Of The Year community,” says Anna Tallent, co-director of the awards’ Central South program.

As regional award winners, these entrepreneurs will be considered for the Entrepreneur Of The Year 2022 national awards, which will be presented in November. The overall Entrepreneur Of The Year winner at the national level then will move on to the EY World Entrepreneur Of The Year program, which will name its top winner in June 2023.

In a news release, Breeze says she’s honored to be given such a prestigious award.

“This award is further validation that at Next Level, we are really on to something. Healthcare needs to be available to patients when and where they need it,” Breeze says.

Aside from the Houston-area winners, here are the other recipients of this year’s Entrepreneur Of The Year Central South Award:

  • CEO Amanda Baldwin and founder and Chairwoman Holly Thaggard of San Antonio-based Supergoop! The company makes and sells sunscreen-based skincare products.
  • Cory Brymer, founder and CEO of Hutto-based BryComm, a provider of technology and security infrastructure services.
  • William Chan, co-founder and CEO of Austin-based Iodine Software, a provider of AI-powered software for the healthcare industry.
  • Todd Dipaola, founder and CEO of Austin-based InMarket, which operates a platform for localized advertising.
  • Dr. David Ferguson, co-founder, president, and CEO of San Antonio-based Celebrate Dental & Braces, which has offices in five states.
  • Mark Floreani, co-founder and CEO of Austin-based FloSports, a streaming service for sporting events.
  • James Garvey, founder and CEO of Austin-based Self Financial, which offers credit-building loans.
  • Tim Heyl, founder and CEO of Austin-based Homeward, whose loans help buyers make all-cash offers for homes.
  • Joel Kocher, co-founder and CEO of Austin- based HumanN, a provider of superfood products.
  • JeVon McCormick, president and CEO of Austin-based book publisher Scribe Media.
  • Thomas Thill, CEO of San Antonio-based AmeriVet Veterinary Partners, an owner and operator of veterinary practices.
This Texas train system is on track to keep operations green, thanks to a Houston-based company. Rendering courtesy of Texas Central

High-speed train hires Houston-based eco company to keep route green

Onboarding

Texas Central, developers of the high-speed train proposed to run between Houston and Dallas, has selected a Houston-based company to oversee the environmental side of the project: Resource Environmental Solutions will help protect and enhance natural ecosystems and the environment throughout construction and operations.

RES will oversee plans to comply with US Army Corps of Engineers' requirements that the project restore, enhance, and preserve wetlands, streams, and environmentally sensitive habitats along the train's route between Houston and North Texas.

According to a release, RES is the largest ecosystem restoration provider in the United States. In the past decade, it has restored more than 58,000 acres of wetlands, enhanced more than 290 miles of streams, and planted more than 14 million restorative trees.

Recent projects include Maurepas Swamp in Louisiana, the Brooks Creek Wetland Mitigation Bank in Bowie County, and the Robinson Fork Stream Mitigation Bank, the largest floodplain restoration project in the northeastern United States.

RES is also working on the Bois d'Arc Lake Mitigation Area, a 16,600-acre reservoir being built in Fannin County to provide water services to 80 communities in North Texas that's the largest permittee-responsible mitigation project in U.S. history. The restoration area encompasses more than 8,500 acres of wetlands, 70 miles of streams, 3,200 acres of native grasslands, and 2,600 acres of non-wetland forests.

RES will help Texas Central meet regulatory requirements for environmental mitigation, collaborating with community leaders to identify local and regional conservation opportunities. The plan includes rebuilding and restoring wetlands and streams in the impacted watersheds, enhancing the viability of sub-watersheds that are close to the route.

Brian Trusty, VP of the Audubon Society, gives a thumbs up, stating that "Audubon believes the project is a win-win opportunity for both Texans and the wildlife in our state."

"Providing large-scale transportation opportunities that work to reduce carbon emissions, while supporting further economic prosperity and connectivity between the Dallas and Houston metro areas, is progressive and forward-looking," Trusty says. "Partnering with RES ensures the project will be done right, and we are thankful to see Texas Central take this step."

The project's scale will allow RES to identify not only isolated pockets along the route that require restoration, but also entire complexes of streams and wetlands suitable for improvement and conservation.

RES will select mitigation sites and designs that collectively improve the ecological functions of broad areas, including some near the Trinity River, Navasota River, Spring Creek, and Cypress Creek.

This environmental work, combined with innovations of an all-electric high-speed train system, will provide the most environmentally friendly travel choice between Houston and North Texas. The train is estimated to remove more than 14,630 cars per day from I-45.

Other ecological benefits:

  • As compared to highway development, for every one mile of high-speed railroad tracks, about 450 acres of farmland will be preserved.
  • The all-electric system will utilize the latest in green technologies, such as regenerative braking systems.
  • Texas will use the newest generation of Shinkansen trains, the N700 Supreme, which consumes seven percent less energy and weighs seven tons less than the previous model. Lighter trains result in less noise, vibration, and impacts on materials and land.
  • The route largely follows existing rights-of-way corridors, resulting in the fewest possible impacts to socioeconomic, natural, physical and cultural environments.

Consistent with Texas Central's commitment to create opportunities for small, minority, women, rural, and veteran-owned businesses, RES has engaged several small businesses to support its work for the project.

RES CEO Elliott Bouillion says in a release that it's possible to achieve both "environmental sustainability and advanced infrastructure."

"Texas high-speed train is an excellent example of how a modern, green infrastructure approach can be harnessed for both ecological and economic benefits," he says.

------

This story originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston startup raises $6M to scale home-based healthcare platform

fresh funding

As healthcare systems race to expand care beyond hospitals and into the home, investors are placing bigger bets on the infrastructure needed to make that shift possible.

This month, Rosarium Health announced it has raised $6 million in seed funding led by Kalos Ventures, with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, Black Tech Nations Ventures and others.

The investment will help the Houston-based startup continue to build its platform, which features a national network of 800-plus clinicians and 3,000-plus contractors to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities.

For founder and CEO Cameron Carter, the company’s mission grew out of firsthand caregiving experiences.

“From my own personal caregiving experiences, I realized that the benefits exist on paper, but not in reality,” Carter said in a news release. “Families are being left to figure out the paperwork and installations all on their own, which shouldn’t be how this works.”

While Medicare Advantage and Medicaid plans have expanded coverage for home-based services and accessibility modifications, the logistics behind delivering those services often remain fragmented.

Rosarium’s platform coordinates the entire process, from clinical assessments and referrals to contractor management, documentation, reimbursement and installation.

“A clinician can document that a home isn’t safe and a plan can approve a benefit, but there’s no one that’s responsible for making sure the work actually gets done,” Carter says. “We built the missing piece.”

The company was founded in 2021 as Rose Health and was a 2023 participant in the Texas Medical Center’s Accelerator for HealthTech program. It has scaled quickly, building a network of more than 800 clinicians and 3,000 contractors across 34 states.

Rosarium is currently in-network for 1.2 million Medicare and Medicaid lives, with projected coverage expected to reach nearly 4 million by the end of the year, according to the release.

“We’re excited to back Cameron because he and the team at Rosarium are building the infrastructure healthcare needs right now to make the home a safe and comfortable place of care,” Kate Ballinger, investor at Kalos Ventures, added in the release.

As part of the recent investment, Ballinger will join Rosarium’s board of directors.

With eyes on the future, Rosarium plans to grow its partnerships with Medicaid and Medicare Advantage plans, including CalViva and Community Health Plan of Imperial Valley, strengthening its presence in California while expanding access to underserved communities.

Additionally, Carter predicts that home-based healthcare will be part of a broader transformation happening across the industry.

“There’s a growing recognition that health outcomes are shaped by what happens in the home,” he said in the release. “The future of healthcare isn’t just treating people after something goes wrong. It’s creating environments that help prevent those problems in the first place.”

4 Houston-area institutions get $8M for cancer research facilities

fighting cancer

Cancer research capabilities in the Houston area just got an $8 million boost.

On Wednesday, May 20, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded $8 million in grants to institutions in Houston and Bryan for the creation or expansion of so-called “core” cancer research facilities.

“Core facilities provide shared access to advanced technology, equipment, and scientific expertise that may not be available at every institution,” CPRIT says. “These core facilities are vital to not only cancer research but also to the study of diseases beyond cancer.”

Houston-area recipients of these $2 million grants are:

  • A facility at the University of Texas Health Science Center for preclinical support of cancer researchers in Texas to evaluate new safe, effective drugs and drug combinations.
  • The Accelerator for Cancer Therapeutics, operated by Houston’s Texas Medical Center Foundation. The accelerator helps researchers and startups move innovative cancer treatments from the lab to clinical trials.
  • Rice University’s Genetic Design & Engineering Center in Houston. The center enables researchers to collaborate on studies of custom DNA for cancer treatment.
  • A facility at the Texas A&M University System’s Health Science Center in Bryan that aims to speed up the development of cancer therapies.

In addition to those grants, the University of Texas M.D. Anderson Cancer Center, Methodist Hospital Research Institute, Baylor College of Medicine, and Rice University shared $21 million to recruit cancer researchers from other institutions.

The largest of those grants—totalling $4 million—went to M.D. Anderson for the recruitment of renowned cancer researcher Andre Nussenzweig from the National Institutes of Health. His research focuses on how DNA damage and faulty DNA repairs lead to cancer.

Here are the totals for the other CPRIT grants awarded in the Houston area:

  • $12.8 million to Houston-based Indapta Therapeutics for the development of an off-the-shelf therapy that naturally kills cancer cells, combined with an immunity-targeting agent for a type of leukemia.
  • $11.1 million to MD Anderson, including $5 million for a statewide platform to improve long-term health outcomes in adolescents and young adults who survived cancer.
  • $8.4 million to Baylor College of Medicine, including $4.8 million for two training programs for cancer researchers.
  • $6.25 million to UT Health Houston, including $4 million for a biomedical informatics and genomics training program for cancer researchers.
  • $4.4 million to the Texas A&M Health Science Center’s Houston campus, including $2.4 million for a cancer therapeutics training program.
  • $2.75 million to Rice, including $250,000 for a study of ovarian cancer.
  • $2 million to Houston-based March Biosciences for the development of a targeted therapy for treating T-cell lymphoma.
  • $1.15 million to the University of Houston, including $900,000 for a platform for detection of lung cancer.
  • $900,000 to Texas A&M in Bryan to conduct clinical drug trials in rural and underserved communities around the state.
  • $800,000 to Houston- and Israel-based Xerient Pharma for the development of an oral form of a cell-protecting drug called amifostine to protect the upper GI tract from radiation damage during pancreatic cancer treatment.
  • $659,000 to Missouri City-based OmniNano Pharmaceuticals for the development of a two-drug combination to treat the most common form of pancreatic cancer.
  • $250,000 to the University of Texas Medical Branch at Galveston for a novel therapeutic to prevent colitis-related colorectal cancer.

Axiom Space launches Japanese subsidiary, names leadership

Axiom Space is setting up a Japanese subsidiary to tap into billions of dollars worth of business opportunities in the vast Asia-Pacific region. The company’s new office in Japan will open July 1.

“For the Asia-Pacific region, an Axiom Space presence in Japan means a long-term, direct path to low-Earth orbit for research, for industry, for astronauts, and a partner committed to building that future together with Japan,” Jonathan Cirtain, president and CEO of Axiom Space, said in a news release.

Asia-Pacific spaceflight leaders include Japan, China, India and South Korea.

Until committing to the Asia-Pacific subsidiary, Axiom focused primarily on the U.S. market for space exploration equipment, technology and services. Axiom is building the successor to the International Space Station (ISS), and it provides human spaceflight services and develops next-generation spacesuits.

Fortune Business Insights estimates the Asia-Pacific market for space technology was valued at $155.3 billion in 2025.

“The region is rapidly expanding due to rapidly expanding government space programs, increasing private sector participation, and rising demand for satellite services across densely populated regions,” says Fortune Business Insights, a market research firm.

The region’s combination of strategic investments, market demand and emerging entrepreneurial systems positions Asia-Pacific “for the fastest growth in the global market,” Fortune Business Insights says.

The market research firm pegs the U.S. market for space technology at $251.8 billion in 2025, making it the world’s largest player in that sector.

Veteran Japanese astronaut Koichi Wakata will lead Axiom Space Japan as chief technology officer in the Asia-Pacific region. The Japanese subsidiary will work with government agencies, research institutions, and industrial partners in Japan to expand hardware development and manufacturing, microgravity research and orbital computing.

Wakata was the Japanese space agency’s first program manager for ISS and the station’s first Japanese commander. He also contributed to the construction of ISS, including the Japanese experiment module Kibo. Wakata retired from the Japanese agency, JAXA, in March 2024.

“Japan intends to remain a leading nation in human space exploration post-ISS, and Japanese industry and academia are ready to play a central role in the commercial era,” Axiom Space said in the release. “Axiom Space Japan is how the company will meet that ambition with a long-term, on-the-ground presence.”